PATTI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 23.090
AS - Asia 12.865
EU - Europa 10.272
SA - Sud America 2.528
AF - Africa 947
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 17
AN - Antartide 1
Totale 49.743
Nazione #
US - Stati Uniti d'America 22.206
SG - Singapore 7.187
CN - Cina 3.815
RU - Federazione Russa 2.673
IE - Irlanda 2.440
BR - Brasile 2.193
UA - Ucraina 1.676
IT - Italia 1.613
CA - Canada 770
VN - Vietnam 636
CI - Costa d'Avorio 534
DE - Germania 420
KR - Corea 370
SE - Svezia 302
GB - Regno Unito 254
IN - India 221
FI - Finlandia 197
SN - Senegal 145
FR - Francia 125
AR - Argentina 122
NL - Olanda 112
BD - Bangladesh 102
PL - Polonia 90
ZA - Sudafrica 82
CH - Svizzera 81
AT - Austria 74
EC - Ecuador 68
MX - Messico 67
TR - Turchia 61
BJ - Benin 53
IQ - Iraq 50
UZ - Uzbekistan 50
JP - Giappone 47
ES - Italia 46
HK - Hong Kong 46
ID - Indonesia 45
VE - Venezuela 41
GR - Grecia 36
PK - Pakistan 33
CZ - Repubblica Ceca 29
LB - Libano 29
CO - Colombia 27
IR - Iran 26
MA - Marocco 26
NG - Nigeria 25
BG - Bulgaria 22
PY - Paraguay 22
EG - Egitto 21
EU - Europa 21
SA - Arabia Saudita 21
TN - Tunisia 21
CL - Cile 19
PE - Perù 17
KE - Kenya 16
LT - Lituania 15
AE - Emirati Arabi Uniti 14
BE - Belgio 14
AU - Australia 13
AZ - Azerbaigian 13
JO - Giordania 13
NP - Nepal 13
IL - Israele 11
HR - Croazia 10
UY - Uruguay 10
DO - Repubblica Dominicana 9
DZ - Algeria 9
RO - Romania 7
HN - Honduras 6
JM - Giamaica 6
KG - Kirghizistan 6
KZ - Kazakistan 6
PA - Panama 6
TH - Thailandia 6
BH - Bahrain 5
OM - Oman 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BO - Bolivia 4
CG - Congo 4
AL - Albania 3
CR - Costa Rica 3
DK - Danimarca 3
GT - Guatemala 3
GY - Guiana 3
HU - Ungheria 3
KW - Kuwait 3
MD - Moldavia 3
RS - Serbia 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BW - Botswana 2
ET - Etiopia 2
GE - Georgia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
Totale 49.699
Città #
Dallas 5.181
Singapore 3.763
Santa Clara 2.523
Dublin 2.428
Chandler 2.040
Jacksonville 1.817
Moscow 1.210
Boardman 1.034
Ashburn 924
Hefei 871
Nanjing 704
Cambridge 658
Lawrence 657
Andover 645
Chicago 568
Toronto 557
Abidjan 534
Catania 388
Seoul 369
Los Angeles 354
Des Moines 328
Houston 282
Beijing 273
San Mateo 253
Wilmington 238
Nanchang 219
Ho Chi Minh City 204
Civitanova Marche 196
Munich 187
Shenyang 179
Hebei 160
São Paulo 154
Ottawa 149
Saint Petersburg 147
Dakar 145
Changsha 135
Jiaxing 135
Tianjin 132
Buffalo 129
Hanoi 124
Helsinki 114
New York 114
Council Bluffs 80
Pune 72
Dong Ket 69
Bremen 67
Rio de Janeiro 66
Grafing 63
Lappeenranta 63
Milan 60
San Francisco 55
Cotonou 53
Norwalk 53
Seattle 53
Rome 52
The Dalles 52
Columbus 51
Warsaw 51
Jinan 50
London 49
Phoenix 49
Amsterdam 48
Redondo Beach 48
Johannesburg 47
Washington 47
Belo Horizonte 46
Brasília 44
Brooklyn 43
Hong Kong 41
Stockholm 41
Tokyo 41
Zhengzhou 39
Denver 38
Curitiba 37
Boston 34
Chennai 34
Hangzhou 33
Ningbo 33
Poplar 33
Porto Alegre 33
Palermo 32
Den Haag 30
Orem 30
Guangzhou 29
Naples 28
Guarulhos 27
Kunming 27
Montreal 26
Atlanta 25
San Jose 24
Baghdad 23
Dhaka 23
Frankfurt Am Main 23
Manchester 23
Salvador 23
Abuja 22
Campinas 22
Haiphong 22
Liberty Lake 22
Mexico City 22
Totale 33.593
Nome #
6. Efficacy of a computer-assisted cognitive rehabilitation protocol on walking in Parkinson's disease patients with freezing of gait: a pilot study 278
A case of multiple autoimmunity complicated by SIADH 277
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 200
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 145
Management of dysphagia in multiple sclerosis: current best practice 143
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 137
Altered time course of changes in the hippocampal concentration of excitatory and inhibitory amino acids during kainate-induced epilepsy 132
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 132
An update on the safety of treating relapsing-remitting multiple sclerosis 130
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 129
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 129
"BoNT/A treatment of Sialorrohea following neurological disorders 128
"Valutazione della efficacia terapeutica di un derivato benzamidico (Tiapride) in alcune sindromi di interesse neurologico". 126
Computer-assisted cognitive rehabilitation on freezing of gait in Parkinson's disease: A pilot study 125
"Effetti della somministrazione cronica di Aloperidolo e Sulpiride sul contenuto di GABA nella Substantia Nigra del ratto". 123
Neurophysiological tests in Multiple Sclerosis. A synthetic overview. 123
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated 122
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 122
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS 121
Cognitive dysfunction in multiple sclerosis. A population based study in Catania, Sicily 120
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 120
Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy 119
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal. 116
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 116
Analisi del cammino di bambini con paralisi cerebrale infantile: modificazioni della cinetica della caviglia dopo trattamento con tossina botulinica di tipo A 115
A waves in electroneurography: differential diagnosis with other late responses 115
"Influenza del sistema dopaminergico centrale sulla attivita' GABAergica del cervelletto". 114
Can new chemical therapies improve the management of multiple sclerosis in children? 112
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 112
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 112
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 111
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily: an update 110
A case of Marburg variant multiple sclerosis: clinical impact after high dose cyclophosphamide treatment 110
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 110
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 110
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement 110
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 110
"Valutazione del behaviour motorio in condizioni di iperprolattinemia". 109
An update on the pharmacological management of pain in patients with multiple sclerosis 109
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily 108
CCSVI and MS. A population-based case-control study in Catania, Sicily. 108
"Convulsioni sperimentali indotte da iniezioni di acido Kainico nei nuclei cerebellari". 107
"Comparative effects of estrogens and Prolactin on nigro-striatal DAergic system: neurochemical and behavioral findings". 107
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 106
Epilepsy and multiple sclerosis 106
"Comparative effect of chronic Haloperidol and Sulpiride treatment on nigral and striatal GABA content". 106
"Calcitonina and nigro-striatal system: neurochemical, behavioural and clinical data". 106
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 106
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 106
"Effects of Hyper and Hypoprolactinemia on glutamate decarboxilase activity in medial basal Hypothalamus of male rat". 105
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily. 104
Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review 102
"La distonia: correlazione tra blink reflex e trattamento farmacologico con Reserpina". 102
Paediatric multiple sclerosis: A scoping review of patients’ and parents’ perspectives 102
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 101
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 101
"Calcitonin effects on extrapyramidal system: clinical and experimenta data". 101
"Modulazione del sistema dopaminergico nigro-striatale da parte di estrogeni e Prolattina: dati comportamentali e neurochimici". 101
The Rao's Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population 101
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 101
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 101
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 100
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 100
Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study 99
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 99
A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis. 98
"Comparative effects of chronic Haloperidol and Sulpiride treatment on nigral-striatal GABA content". 97
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 97
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 96
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 96
"Drug-use, non-use and misuse: Carbamazepine in cluster headache therapy". 96
Frequency of celiac disease is not increased among multiple sclerosis patients 96
Multicenter, prospective, observational study aimed at evaluating SAtivex efFEcts (effectiveness and tolerability) in a large population of Italian multiple sclerosis patients: SA. FE. study 96
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany 96
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 95
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 95
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 94
Calcitonin and migraine 94
The impact of outpatient rehabilitation on quality of life in multiple sclerosis 94
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 94
Clinical Evolution of Relapsing Remitting Late Onset Multiple Sclerosis: A Nine Year Follow-Up Study 94
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study 94
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients 94
Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study 94
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 94
Didattica delle encefalopatie spongiformi 93
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 93
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 92
"Depressione: una medesima etichetta per distinte entità neurochimiche". 92
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS 92
Pharmacoeconomics of synthetic therapies for multiple sclerosis 92
Reply to Comment on “Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study” 92
Effects of Zn++ sulphate on limbic motor seizures indiced by kainic acid [Effetti del solfato di zinco sulla epilessia motoria limbica indotta da acido Kainico] 91
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 91
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience 91
MULTIDISCIPLINARY APPROACH OF AMYOTROPHICLATERAL SCLEROSIS:A CENTRE EXPERIENCE 90
Palliative care in progressive multiple sclerosis 90
"Valutazione retrospettiva della terapia medica nella insufficienza cerebro-vascolare acuta e subacuta". 90
Effects of dopaminergic drugs on cerebellar prostaglandin concentrations 90
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives 90
Totale 11.041
Categoria #
all - tutte 187.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.356 0 0 0 0 0 80 323 15 303 36 407 192
2021/20224.494 553 694 30 87 704 17 684 142 360 12 153 1.058
2022/20237.005 699 208 103 495 711 1.252 34 1.240 1.841 61 263 98
2023/20242.831 179 420 153 162 115 461 80 166 33 94 623 345
2024/202511.648 99 1.577 819 382 2.351 1.066 342 519 1.095 1.526 788 1.084
2025/202617.114 1.530 2.237 4.896 1.898 4.346 2.207 0 0 0 0 0 0
Totale 50.905